A systematic review of the PubMed and Google Scholar medical databases and identified 38 cases of primary esophageal diffuse large B-cell lymphoma (DLBCL), highlighting the challenging diagnosis and therapeutic management of this uncommon presentation.
Abstract
Esophageal involvement in non-Hodgkin lymphoma (NHL) is uncommon and generally secondary to disseminated disease. Primary esophageal NHL is extremely rare, with only a few cases reported in the literature. We conducted a systematic review of the PubMed and Google Scholar medical databases and identified 38 cases of primary esophageal diffuse large B-cell lymphoma (DLBCL). The majority of the patients were male, with a median age of 60 years. Progressive dysphagia was the primary symptom. The ituximab, cyclophosphamide, oncovin, and vincristine (RCHOP) regimen is the mainstay of treatment. We report an additional case of primary esophageal DLBCL, highlighting the challenging diagnosis and therapeutic management of this uncommon presentation.
The case of an elderly male diagnosed with lymphoma at the base of the tongue, with splenic involvement identified by PET-CT scan, and the patient received systemic chemotherapy.
Siddhartha Nanda, Papuji Meher, Mukesh Kumar et al.· Exclusive Real World Evidenc...· 0 citations
Primary breast lymphoma is a rare extranodal manifestation of non-Hodgkin lymphoma, accounting for less than 0.5% of all breast malignancies and approximately 1–2% of extranodal lymphomas. Although diffuse large B-cell lymphoma is the most frequently reported subtype, other indolent B-cell lymphomas can also occur. We...
Lembarki Sarah, El Malki Fatima Ez-Zahrae, F. Laamrani et al.· Radiology Case Reports· 0 citations
Primary thyroid diffuse large B-cell lymphoma (DLBCL) is a rare subset of primary extranodal DLBCL. Thus, there are limited evidence-based specific recommendations regarding its diagnosis and treatment. We present a case report of a patient with relapsed primary thyroid DLBCL, followed by a focused literature review co...
K. Kirkgöz, K. Weisel, Carsten Bokemeyer et al.· Annals of Hematology· 0 citations
It is suggested that careful determination of surgical margins and comprehensive staging evaluations—including whole-body PET-CT, sentinel lymph node biopsy, and long-term postoperative follow-up—may be considered for patients with tumors exceeding 2.0 cm.
Silverberg Li, Fang Yang, Yang-Yang Jiang et al.· Frontiers in Oncology· 0 citations
Leptomeningeal carcinomatosis from esophageal cancer is a rare and clinically aggressive complication of solid tumors, characterized by heterogeneous presentation, frequent diagnostic delay, and poor prognosis.
A. Mylonakis, Dimosthenis Stylios, D. Tsilimigras et al.· Diseases of the esophagus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.